Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0002012383-25-000425
Filing Date
2025-02-04
Accepted
2025-02-04 13:32:15
Documents
3

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G  
1 primary_doc.xml SCHEDULE 13G 6584
2 EXHIBIT 24: POWER OF ATTORNEY PowerOfAttorney.txt EX-24 2797
3 EXHIBIT 99: ITEM 7 ITEM7.txt EX-99 491
  Complete submission text file 0002012383-25-000425.txt   11751
Mailing Address 1101 PENNSYLVANIA AVENUE NW SUITE 300 WASHINGTON DC 20004
Business Address 1101 PENNSYLVANIA AVENUE NW SUITE 300 WASHINGTON DC 20004 202-756-2245
ASP Isotopes Inc. (Subject) CIK: 0001921865 (see all company filings)

EIN.: 872618235 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G | Act: 34 | File No.: 005-94207 | Film No.: 25586757
SIC: 2890 Miscellaneous Chemical Products
(CF Office: 08 Industrial Applications and Services)

Mailing Address 50 HUDSON YARDS NEW YORK NY 10001
Business Address 50 HUDSON YARDS NEW YORK NY 10001 (212) 810-5800
BlackRock, Inc. (Filed by) CIK: 0002012383 (see all company filings)

EIN.: 991116001 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G
SIC: 6211 Security Brokers, Dealers & Flotation Companies
(CF Office: 02 Finance)